Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Methapmhetamine Withdrawal: How to Manage?
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psychiatry In Depth
Page 1 of 1
Methapmhetamine Withdrawal: How to Manage?
Methapmhetamine Withdrawal: How to Manage?
The following notes are compiled from articles published on PubMed. This will help you in recognizing sign & symptoms, and treatment of methamphetamine withdrawal. I don't have much experience with meth using patients. Please add your experience. Thanks
Signs & Symptoms:
- The DSM IV-TR identifies dysphoric mood as the main symptom for amphetamine (including MA) withdrawal, and requires at least two of the following additional symptoms for a positive diagnosis: fatigue, insomnia or hypersomnia, increased appetite, psychomotor agitation or retardation and vivid, unpleasant dreams
- Depressive symptoms, a core criterion for the diagnosis of cocaine or amphetamine withdrawal, are substantially higher in stimulant-dependent individuals than in the general community and are commonly identified in treatment samples of amphetamine users.
- Amphetamine users experiences depression that peaks at 48–72 hours following the last amphetamine dose (Source: American Journal of Psychiatry, 129, 263–269.)
- Some may also experience "Crash Phase" of around 3 days following the cessation of
amphetamine use: during which the individual may sleep for much of the time, may be followed by a prolonged period of insomnia.
- First week (Acute Phase): characterized principally by increases in sleeping and appetite.
- A cluster of depression-related symptoms (including inactivity, fatigue, anhedonia and dysphoria): marked during the first week, but largely resolves by the end of the acute phase of abstinence.
- Less severe symptoms of withdrawal: anxiety, motor retardation, agitation, vivid dreams, craving, poor concentration, irritability and tension.
- Levels of paranoid and suicidal ideation remains low throughout the first 3 weeks of abstinence.
- Unlike alcohol or opioid withdrawal, there were no directly measurable amphetamine withdrawal signs as objective measures such as pulse and blood pressure remains within normal limits. (*)
- Methamphetamine Withdrawal Questionnaire (MAWQ) can also be used daily to access the withdrawal symptoms.
- Until now the association between psychotic symptoms and MA withdrawal and abstinence has not been well characterized. Although psychotic symptoms are not a diagnostic feature of MA withdrawal, they are often prominent during early abstinence. (Source: Am J Addict. 2008 Mar-Apr;17(2):83-98.)
Treatment:
- No medication is effective for treatment of amphetamine withdrawal.
- Amineptine showed reduction in discontinuation rates and improvement in clinical presentation compared to placebo, but had no effect on reducing withdrawal symptoms or craving.
- In spite of these limited benefits, amineptine is not available for use due to concerns over abuse liability when using the drug.
- The benefits of mirtazapine as a withdrawal agent are less clear based on findings from two randomised controlled trials: one report showed improvements in amphetamine withdrawal symptoms over placebo; a second report showed no differences in withdrawal symptoms compared to placebo.
Source: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003021.
Similar topics
» Pharmacological Treatments of Non-Substance-Withdrawal Delirium
» Alcohol Withdrawal- Management
» Antipsychotic of choice in Alcohol Withdrawal
» Mechanism for hyperreflexia in Alcohol Withdrawal ?
» Caffeine Withdrawal Recommended for Inclusion in DSM-5
» Alcohol Withdrawal- Management
» Antipsychotic of choice in Alcohol Withdrawal
» Mechanism for hyperreflexia in Alcohol Withdrawal ?
» Caffeine Withdrawal Recommended for Inclusion in DSM-5
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psychiatry In Depth
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin